ABIO logo

ARCA Biopharma (ABIO) Non Current Assets

ABIO Annual Non Current Assets

$430.00 K
+$44.00 K+11.40%

31 December 2023

ABIO Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABIO Quarterly Non Current Assets

$24.00 K
-$12.00 K-33.33%

30 June 2024

ABIO Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABIO Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.4%-91.1%
3 y3 years-6.7%-95.4%
5 y5 years+795.8%-95.4%

ABIO Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-98.2%-99.9%

ARCA Biopharma Non Current Assets History

DateAnnualQuarterly
June 2024
-
$24.00 K(-33.3%)
Mar 2024
-
$36.00 K(-86.6%)
Dec 2023
$37.43 M(-12.3%)
$269.00 K(-7.9%)
Sept 2023
-
$292.00 K(-11.0%)
June 2023
-
$328.00 K(-8.1%)
Mar 2023
-
$357.00 K(-7.5%)
Dec 2022
$42.70 M(-21.5%)
$386.00 K(-7.0%)
Sept 2022
-
$415.00 K(-7.0%)
June 2022
-
$446.00 K(-6.1%)
Mar 2022
-
$475.00 K(-5.6%)
Dec 2021
$54.42 M(+8.9%)
$503.00 K(-4.4%)
Sept 2021
-
$526.00 K(-3.5%)
June 2021
-
$545.00 K(+20.3%)
Mar 2021
-
$453.00 K(-1.7%)
Dec 2020
$49.97 M(+489.2%)
$461.00 K(+902.2%)
Sept 2020
-
$46.00 K(-23.3%)
June 2020
-
$60.00 K(-27.7%)
Mar 2020
-
$83.00 K(+48.2%)
Dec 2019
$8.48 M(+25.1%)
$56.00 K(+24.4%)
Sept 2019
-
$45.00 K(-30.8%)
June 2019
-
$65.00 K(-25.3%)
Mar 2019
-
$87.00 K(+81.3%)
Dec 2018
$6.78 M(-44.9%)
$48.00 K(-9.4%)
Sept 2018
-
$53.00 K(-7.0%)
June 2018
-
$57.00 K(-6.6%)
Mar 2018
-
$61.00 K(-7.6%)
Dec 2017
$12.30 M(-42.6%)
$66.00 K(-87.9%)
Sept 2017
-
$545.00 K(-15.0%)
June 2017
-
$641.00 K(-12.8%)
Mar 2017
-
$735.00 K(-76.9%)
Dec 2016
$21.45 M(-44.9%)
$3.18 M(-34.9%)
Sept 2016
-
$4.89 M(-17.1%)
June 2016
-
$5.90 M(-0.2%)
Mar 2016
-
$5.91 M(+798.2%)
Dec 2015
$38.92 M(+151.3%)
$658.00 K(-7.3%)
Sept 2015
-
$710.00 K(-9.9%)
June 2015
-
$788.00 K(+34.2%)
Mar 2015
-
$587.00 K(-8.9%)
Dec 2014
$15.49 M(-8.5%)
$644.00 K(+12.2%)
Sept 2014
-
$574.00 K(-33.3%)
June 2014
-
$860.00 K(+0.7%)
Mar 2014
-
$854.00 K(+437.1%)
Dec 2013
$16.93 M(+455.8%)
$159.00 K(+25.2%)
Sept 2013
-
$127.00 K(+1.6%)
June 2013
-
$125.00 K(-14.4%)
Mar 2013
-
$146.00 K(-12.6%)
Dec 2012
$3.04 M(-51.0%)
$167.00 K(-15.2%)
Sept 2012
-
$197.00 K(-12.8%)
June 2012
-
$226.00 K(-11.7%)
Mar 2012
-
$256.00 K(-11.7%)
Dec 2011
$6.21 M(-13.3%)
$290.00 K(-29.3%)
Sept 2011
-
$410.00 K(-45.6%)
June 2011
-
$754.00 K(-15.2%)
Mar 2011
-
$889.00 K(-10.6%)
Dec 2010
$7.16 M
$994.00 K(+20.0%)
DateAnnualQuarterly
Sept 2010
-
$828.00 K(-9.6%)
June 2010
-
$916.00 K(-8.6%)
Mar 2010
-
$1.00 M(-29.1%)
Dec 2009
$7.96 M(-17.8%)
$1.41 M(-80.4%)
Sept 2009
-
$7.23 M(-50.3%)
June 2009
-
$14.55 M(-1.7%)
Mar 2009
-
$14.81 M(+956.8%)
Dec 2008
$9.68 M(-90.3%)
$1.40 M(-90.3%)
Sept 2008
-
$14.48 M(-3.7%)
June 2008
-
$15.04 M(-25.6%)
Mar 2008
-
$20.23 M(-2.3%)
Dec 2007
$99.99 M(-39.9%)
$20.70 M(-2.7%)
Sept 2007
-
$21.26 M(+34.2%)
June 2007
-
$15.84 M(-9.4%)
Mar 2007
-
$17.49 M(-3.2%)
Dec 2006
$166.34 M(+93.9%)
$18.07 M(-21.0%)
Sept 2006
-
$22.86 M(+1.6%)
June 2006
-
$22.51 M(+0.1%)
Mar 2006
-
$22.49 M(+0.9%)
Dec 2005
$85.77 M(+30.0%)
$22.28 M(+2.3%)
Sept 2005
-
$21.78 M(+22.0%)
June 2005
-
$17.85 M(+39.0%)
Mar 2005
-
$12.84 M(-3.2%)
Dec 2004
$66.00 M(+65.6%)
$13.27 M(-10.0%)
Sept 2004
-
$14.74 M(-7.8%)
June 2004
-
$15.99 M(-5.6%)
Mar 2004
-
$16.94 M(-5.6%)
Dec 2003
$39.86 M(+577.6%)
$17.95 M(-9.1%)
Sept 2003
-
$19.74 M(-0.0%)
June 2003
-
$19.75 M(-17.5%)
Mar 2003
-
$23.93 M(+12.9%)
Dec 2002
$5.88 M(-63.9%)
$21.19 M(+5.3%)
Sept 2002
-
$20.13 M(-8.3%)
June 2002
-
$21.96 M(-4.3%)
Mar 2002
-
$22.95 M(-2.8%)
Dec 2001
$16.30 M(+189.7%)
$23.60 M(+21.1%)
Sept 2001
-
$19.50 M(+7.2%)
June 2001
-
$18.19 M(+4.2%)
Mar 2001
-
$17.46 M(+11.5%)
Dec 2000
$5.63 M(-82.9%)
$15.66 M(+2.6%)
Sept 2000
-
$15.27 M(+12.5%)
June 2000
-
$13.57 M(+14.8%)
Mar 2000
-
$11.82 M(-4.7%)
Dec 1999
$33.00 M(-31.5%)
$12.40 M(+5.1%)
Sept 1999
-
$11.80 M(+11.3%)
June 1999
-
$10.60 M(+2.9%)
Mar 1999
-
$10.30 M(+6.2%)
Dec 1998
$48.20 M(-19.9%)
$9.70 M(0.0%)
Sept 1998
-
$9.70 M(+11.5%)
June 1998
-
$8.70 M(+11.5%)
Mar 1998
-
$7.80 M(+14.7%)
Dec 1997
$60.20 M(+736.1%)
$6.80 M(+78.9%)
Sept 1997
-
$3.80 M(+11.8%)
June 1997
-
$3.40 M(+54.5%)
Mar 1997
-
$2.20 M
Dec 1996
$7.20 M
-

FAQ

  • What is ARCA biopharma annual long term assets?
  • What is the all time high annual non current assets for ARCA biopharma?
  • What is ARCA biopharma annual non current assets year-on-year change?
  • What is ARCA biopharma quarterly long term assets?
  • What is the all time high quarterly non current assets for ARCA biopharma?
  • What is ARCA biopharma quarterly non current assets year-on-year change?

What is ARCA biopharma annual long term assets?

The current annual non current assets of ABIO is $430.00 K

What is the all time high annual non current assets for ARCA biopharma?

ARCA biopharma all-time high annual long term assets is $23.60 M

What is ARCA biopharma annual non current assets year-on-year change?

Over the past year, ABIO annual long term assets has changed by +$44.00 K (+11.40%)

What is ARCA biopharma quarterly long term assets?

The current quarterly non current assets of ABIO is $24.00 K

What is the all time high quarterly non current assets for ARCA biopharma?

ARCA biopharma all-time high quarterly long term assets is $23.93 M

What is ARCA biopharma quarterly non current assets year-on-year change?

Over the past year, ABIO quarterly long term assets has changed by -$245.00 K (-91.08%)